Hyris bKIT Virus Finder Covid-19 is the first commercially available, rapid COVID-19 medical device approved by Health Canada for point-of-care human testing. Exclusively distributed by Songbird Life Science, it is fast becoming the preferred choice of industry leaders across Canada.

Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.

Hyris Ltd first ranking for the Regione Lombardia COVID-19 Research fund with the project: COVES – Sviluppo e validazione di una metodica rapida per la rilevazione di SARS-CoV-2 su superfici ambientali

“Surveillance of mosquito infection status is critical for planning and deployment of proper mosquito control initiatives. Concurrently, Wolbachia is being widely used as a control method for arboviral transmission. Point-of-care (POC) detection assays are necessary for monitoring the infection prevalence and geographic range of viruses as well as Wolbachia in mosquito vector populations.“

We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

Toronto based Purity-IQ Inc., has partnered exclusively with Hyris, a leader in Artificial Intelligence applications for advanced diagnostics with offices in London, Milan and Singapore, to support their business expansion in the Americas.

The identification of infected surfaces is a key step to fight COVID-19 spreading.  Thanks to our new kit, the detection of COVID-19 Environmental contamination is now easy, fast and accurate.

Hyris Trade Fairs Analytica, March 31^st to April 3^rd 2020, Messe München

Hyris and Generon: new strategic cooperation agreement.

Various reports have estimated approximately 30% of biomass materials sold for human consumption are not what is declared on the label. As such, Indena has applied DNA barcoding to validate the content of its natural ingredients—starting with bilberry.

SAN FRANCISCO — Researchers developed a highly sensitive quantitative PCR, or qPCR, method for the detection and quantitation of dengue and Zika virus in individual mosquitoes using the portable Hyris bCUBE device, introducing a new tool for mosquito surveillance in areas facing outbreaks, according to data presented at ASM Microbe.

London, 24 June 2019: EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.

A species-specific hydrolysis probe assay was developed, validated, and evaluated for the performance of the assay in accurately identifying the species of interest using the following analytical validation criteria:

Hyris introduces probiotic bKITs, fully working with our bCUBE device.

Check our catalog HERE and do not forget to subscribe to our mailing list to be up to date with our products (see bottom).

PCR methods are the most commonly used DNA-based identity tool in the commercial food, beverage, and natural health product markets.

These methods are routinely used to identify foodborne pathogens and allergens in food. Proper validation methods for some sectors have been established, while they are still in development in other markets, such as botanicals. A survey of the literature indicates that some validation criteria are not addressed when developing PCR tests for botanicals.

We provide recommendations for qualitative real-time PCR methods for validating identity tests for botanical ingredients.

University of Guelph

Nature's Bounty

Herbalife

Hyris ltd

FULL ARTICLE LINK